A Phase Ib Study to Evaluate Safety and Efficacy Profiles of IOP Injection for Magnetic Resonance Imaging (MRI) Contrast Agent in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2018
Price : $35 *
At a glance
- Drugs Iron oxide-PEG (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- Sponsors Megapro Biomedical Company
- 15 Aug 2018 Status changed from not yet recruiting to completed.
- 22 Jan 2018 New trial record